©LTPHN 2008 Blood Pressure – the highs and lows Speaker, name,affiliation,etc.

Slides:



Advertisements
Similar presentations
1 Item code: Print date: Not applicable 1.
Advertisements

Treatment of Hypertension
The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.
The Risk Concept in health care Definition of a risk factor  a disease precursor associated with a higher than average morbidity or mortality rate. John.
ASCOT ASCOT STUDY. ASCOT INTRODUCTION AND AIMS EXISTING KNOWLEDGE BACKGROUND OF ASCOT STUDY DESIGN (TWO ARMS (BPLA,LLA) METHODOLOGY TREATMENT REGIMES.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Population Health Gain in Primary Care Dr Hilary Guite FFPH MRCGP Consultant Public Health Medicine Public Health England
CVD risk estimation and prevention: An overview of SIGN 97.
Hypertensive Emergencies Malcolm A. Lewis Consultant Paediatric Nephrologist.
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
Health risks of smoking Principal fatal diseases caused by smoking are cancer, COPD and CVD In addition, smoking is an important cause of morbidity Risks.
 Currently 150 Million people worldwide suffering from diabetes and that number may double by the year  The prevalence of type 2 diabetes is dramatically.
Presentation Package for Concepts of Physical Fitness 14e
Epidemiological and nutritional transition in Mexico: rapid increase
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Ian Graham et al. European Heart Journal 2007;28:
Diabetes Mellitus Type 2
Epidemiology Prevalence Increase with age 25% of the white males vs. 17% in white females 44% of black males vs. 37% in black femals Indifference between.
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
MORBID OBESITY A Heavy Burden.... What is Morbid Obesity? A person is classified as morbidly obese when their BMI is greater than 40, or they are more.
RENAL DISEASE IN DIABETES
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
What is an AEP?. AEPs specialise in clinical exercise interventions for a broad range of pathological populations.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Cardiovascular Disease in Women Module I: Epidemiology.
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
EXAM 1.A normal adult should have their BP checked at least how often? 2.What level of CVD risk over 10 years is considered high risk for primary prevention?
«Blood stroke» Abdurashitov & Bezsonov. Stroke.What is? A stroke, or cerebrovascular accident (CVA), is the rapid loss of brain function(s) due to disturbance.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
Blood pressure control in primary health care WORKSHOP
1 Improving Chronic Care Management David M. Cutler Presented at Alliance for Health Reform Novartis/NIHCM Briefing March 28, 2008.
P HYSICAL A CTIVITY B ENEFITS Reduce Diabetes Reduce Depression Increase Awareness of CVD Increase Cardiovascular Health.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
HvC Comparative Effectiveness Project Groups 5 and 6
7/27/2006 Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Lisinopril* * Wright JT, Dunn JK, Cutler JA.
Double Jeopardy. International Diabetes Federation Diabetes State of raised blood glucose (hyperglycaemia) associated with premature mortality Pancreas.
NHS Health Check NHS Health Check Programme in Norfolk Presented by Justine Hottinger.
Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.
SAM OTI Implementation, outcomes and associated costs of a community- based intervention for hypertension management in an urban slum in Kenya.
1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.
ASSOCIATED CONDITIONS WITH DIABETES MELLITUS TYPE II.
Alcohol Drugs and Hepatitis C, Brewing up a perfect storm COSLA Haymarket, Edinburgh 24 June 2015 Epidemiological overview Professor David Goldberg, Health.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Date of download: 6/28/2016 From: Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis Ann Intern Med. 2015;162(3):
Hypertension guidelines What’s all the controversy about 2015
Golden Rules to Keep Kidneys Healthy
Preventing Cardiovascular Disease
for your Total Blood Sugar Support
What’s New in the 2013 ESC/ESH Hypertension Guideline
Prevention in Cardiovascular Disease
Copyright © 2007 American Medical Association. All rights reserved.
High Blood Pressure (Hypertension)
Improving Chronic Care Management
برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Department of General Practice QUB
Guidelines for the Older Adult With CKD
Homocysteine and risk in end-stage renal disease: a matter of context
Goals & Guidelines A summary of international guidelines for CHD
CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.
Meta-analysis of trials examining the effects of aspirin on risk of CVD events in patients with diabetes. Meta-analysis of trials examining the effects.
Presentation transcript:

©LTPHN 2008 Blood Pressure – the highs and lows Speaker, name,affiliation,etc

©LTPHN 2008 Why is Blood Pressure Important? Raised BP is a known risk factor for CHD CVD Renal disease

©LTPHN 2008 ‘Rule of Halves’ Currently, about Half the people with raised BP are unaware of it Half of those who are aware are on optimal management

©LTPHN 2008 Causes of hypertension Idiopathic – by far the commonest Drugs – esp OTC And rarer causes: Renal disease Phaeocromocytoma Conn’s syndrome Coarctation Cushing’s

©LTPHN 2008 Special Groups at risk People with diabetes mellitus (Type I and II) During pregnancy

©LTPHN 2008 Evidence-Based Treatment Goals Aim: to reduce mortality and preventable morbidity General population: <140/<85 For people with diabetes, chronic renal or CVD: <130/<80

©LTPHN 2008 ‘White Coat Hypertension’ Artefact: raised BP in doctor’s surgery or hospital More common in women Lesson: always have more than one raised reading before diagnosis Ambulatory BP monitoring excludes

©LTPHN 2008 Epidemiology – population impact Prevalence: 25% adults in developed countries Prevalence increases with age – older people do not naturally have ‘higher than normal’ BP Risk of adverse events greater in women 10% weight loss associated with 10mmHg decrease in systolic BP, 20mmHg diastolic BP Weight gain associated with rise in systolic Ethnicity: In UK, African Caribbeans at highest risk of H/T

©LTPHN 2008 Racial & Ethnic Influences Are explained by: Genetic Pathophysiological Environmental Dietary Psychosocial factors

©LTPHN 2008 Socioeconomic factors More common in poorest SE groups: Correlates with lifestyle factors – lack of exercise obesity salt intake smoking

©LTPHN 2008 Impact of Lifestyle Lifestyle modification can decrease BP: Reduce dietary saturated fat, cholesterol, sodium; maintain adequate intake K,Ca,Mg Attain normal body weight Moderate alcohol intake [3u/day men; 1.5/day women] Aerobic physical activity Stop smoking BUT Compliance often poor at individual or population level

©LTPHN 2008 Potential impact of lifestyle changes Morbidity - lower incidence of hypertension In known hypertensive patients, fewer prescribed drugs needed – fewer side effects Macroeconomic - lower prescribing costs Self management – promoting patient empowerment

©LTPHN 2008 BP and cardiovascular risk BP should be seen in context of overall CVD risk Charts of risk prediction readily available Absolute risk is meaningful to the public